Causative factors for prolonged hospitalization beyond the point of engraftment in patients after autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 26, Issue 8, 2000, Pages 877-880

  CetkovskY P ^a   skopek P ^a   Schutzova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cost effectiveness; Granulocyte colony stimulating factor (G CSF); Hematopoietic reconstitution; Non hematological toxicity; Peripheral blood stem cell transplatation (PBSCT)

Indexed keywords

ACICLOVIR; CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MELPHALAN; QUINOLONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTEREMIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HODGKIN DISEASE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NAUSEA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; VOMITING;

ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033754194     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702632     Document Type: Article

References (18)

1. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic functions following marrow ablative therapy
2. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit
3. Recombinant granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for lymphoid cancer
4. Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation
5. Delayed G-CSF after autologous progenitor cell transplantation: A prospective randomized trial
6. Costs of intensive treatment and follow-up of patients with multiple myeloma
7. The economic evaluation of hematopoietic growth factors in high dose chemotherapy
8. Colony-stimulating factors and peripheral blood progenitor cell transplantation: Benefits and costs
9. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial
10. Athome management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies
11. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. A randomized, controlled trial
12. Factors that influence collection and engraftment of autologous peripheral-blood stem cells
13. Delays in discharge from hospital after haematological recovery from peripheral blood stem cell transplantation: Is recovery from gut toxicity an important factor?
14. Rapid engraftment does not shorten the duration of hospital stay in some patients after peripheral blood stem cell transplantations (PBSCT)
15. 2 and G-CSF is an effective and safe outpatient-based PBSC mobilizing regimen: A single centre experience
16. Peripheral stem cell mobilization and engraftment in patients over age 60
17. Patients characteristics associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma
18. Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells